| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.049 | 0.4 |